| Financial Year |
March 31 2023 |
| Monetary Funds |
3,654,387,290.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,851,552.00 |
| Accounts Receivable |
1,380,539,137.18 |
| Advances to Suppliers |
729,387,095.60 |
| Other Receivables |
272,375,375.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,787,152,923.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
572,728,545.74 |
| Total Current Assets |
8,409,421,919.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
75,675,800.23 |
| Investment Properties |
-- |
| Fixed Assetes |
2,118,357,675.11 |
| Under-construction Projects |
165,598,063.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
810,938,529.57 |
| R&D expenses |
2,015,826.15 |
| Goodwill |
4,216,307,189.74 |
| Long-Term Deferred and Prepaid Expenses |
3,344,523,042.07 |
| Deferred Income Tax Assets |
430,993,328.87 |
| Other Non-Current Assets |
95,351,105.94 |
| Sub-Total of Non-Current Assets |
18,054,771,259.83 |
| Total Assets |
26,464,193,179.82 |
| Short-Term Loans |
3,133,351,320.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,363,005,831.09 |
| Accounts Received In Advance |
191,336,398.35 |
| Employee Compensation Payable |
296,569,839.64 |
| Taxes Payable |
86,068,938.46 |
| Interest Payable |
-- |
| Dividend Payable |
537,600.00 |
| Other payables |
1,371,671,981.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
895,507,969.81 |
| Other Current Liabilities |
20,224,457.99 |
| Sub-Total of Current Liabilities |
9,098,095,110.53 |
| Long-term Loans |
2,177,542,198.81 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
296,181,773.70 |
| Deferred Income Tax Liabilities |
5,128,954.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,899,557,844.64 |
| Total Liabilities |
18,997,652,955.17 |
| Paid-In Capital(Or Share Stock) |
2,179,368,810.00 |
| Capital Surplus |
10,889,883,121.57 |
| Surplus Reserve |
561,144,336.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,121,784,248.12 |
| Minority Stockholder's Interest |
121,262,098.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,345,278,126.24 |
| Owner's Equity（Stockholder's Equity） |
7,466,540,224.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,464,193,179.82 |
